TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1724390

Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte colony-stimulating factor (rhG-CSF) 0.5 micrograms/kg injected subcutaneously for 6 consecutive days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte colony-stimulating factor (rhG-CSF)
Number of subjects: 0
Study: 6362553

Group type: EXPERIMENTAL
Intervention: Amoxicillin‐clavulanic acid (A‐C) for 10 days
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cefaclor for 10 days
Number of subjects: 66
Study: 3543835

Group type: EXPERIMENTAL
Intervention: Hexcelite
Number of subjects: 82

Group type: COMPARATOR
Intervention: Plaster of Paris
Number of subjects: 82
Study: 29765151

Group type: EXPERIMENTAL
Intervention: Apatorsen plus docetaxel (A/D)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 200
Study: 29083220

Group type: EXPERIMENTAL
Intervention: Mindfulness-based relapse prevention (MBRP)
Number of subjects: 454

Group type: COMPARATOR
Intervention: Cognitive-behavioral relapse prevention
Number of subjects: 454

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 454
Study: 24714660

Group type: COMPARATOR
Intervention: 600 IU/day of vitamin D (control group, n = 31)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 1,200 IU/day of vitamin D (n = 31)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 2,000 IU/day of vitamin D (n = 32)
Number of subjects: 91
Study: 23972694

Group type: EXPERIMENTAL
Intervention: GXR administered in the morning (1-4 mg/d)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: GXR administered in the evening (1-4 mg/d)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Placebo administered twice daily
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: GXR all-active (morning and evening)
Number of subjects: 333
Study: 20339952

Group type: EXPERIMENTAL
Intervention: Cardiac auscultation curriculum (computer tutorial and cardiac patient simulator)
Number of subjects: 108
Study: 17976225

Group type: EXPERIMENTAL
Intervention: Deep anesthesia with desflurane (25% concentration)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Light anesthesia with desflurane (50% concentration)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (deep and light)
Number of subjects: 20
Study: 16761155

Group type: EXPERIMENTAL
Intervention: Day hospital nurses handling antineoplastic drugs
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ward nurses and pharmacy technicians
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lymphocytes from exposed groups
Number of subjects: 30
Study: 12409635

Group type: EXPERIMENTAL
Intervention: Pravastatin (n = 1,422)
Number of subjects: 2232

Group type: COMPARATOR
Intervention: Diet therapy (n = 810)
Number of subjects: 2232
Study: 9836156

Group type: EXPERIMENTAL
Intervention: 70% isopropyl alcohol cleansing at each diaper change
Number of subjects: 1811

Group type: COMPARATOR
Intervention: Natural drying of the umbilical site without special treatment
Number of subjects: 1811
Study: 7915921

Group type: EXPERIMENTAL
Intervention: 50 micrograms salmeterol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 24 micrograms formoterol
Number of subjects: 16

Group type: COMPARATOR
Intervention: 200 micrograms salbutamol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2910758

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg twice daily for 1 week)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cimetidine (50 mg/kg body wt) in rats
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cimetidine (in vitro)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no cimetidine)
Number of subjects: 6
Study: 1275144

Group type: EXPERIMENTAL
Intervention: Wound drainage
Number of subjects: 92

Group type: COMPARATOR
Intervention: No wound drainage (Control)
Number of subjects: 92
Study: 31641887

Group type: EXPERIMENTAL
Intervention: Sitagliptin (50 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Voglibose (0.6 mg/day)
Number of subjects: 30
Study: 30360748

Group type: EXPERIMENTAL
Intervention: Oral Levofloxacin (TAVANEX), 750 mg, once daily for five days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Parenteral Ceftriaxone 1gr BD plus oral Azithromycin (250 mg, once daily) for seven to ten days
Number of subjects: 150
Study: 27759629

Group type: EXPERIMENTAL
Intervention: Carbon nanoparticles (CNs)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study: 24807156

Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Bevacizumab 15 mg/kg
Number of subjects: 303

Group type: COMPARATOR
Intervention: Bevacizumab (both dosages)
Number of subjects: 303
Study: 22455751

Group type: EXPERIMENTAL
Intervention: Premier HQID hospitals
Number of subjects: 3363

Group type: COMPARATOR
Intervention: Control hospitals (public reporting only)
Number of subjects: 3363

Group type: EXPERIMENTAL
Intervention: Premier HQID hospitals (poor performers at baseline)
Number of subjects: 3363

Group type: COMPARATOR
Intervention: Control hospitals (poor performers at baseline)
Number of subjects: 3363
Study: 20197510

Group type: EXPERIMENTAL
Intervention: High tobacco smoke exposure (high cotinine group)
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Intermediate tobacco smoke exposure (intermediate cotinine group)
Number of subjects: 494

Group type: COMPARATOR
Intervention: Low tobacco smoke exposure (low cotinine group)
Number of subjects: 494
Study: 18824931

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg x kg(‐1))
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Aspirin (10 mg x kg(‐1))
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 15597182

Group type: EXPERIMENTAL
Intervention: Two-dimensional stimulus-response set in Experiment 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-dimensional Simon tasks with two contralateral effectors in Experiments 2 and 3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Horizontal coding in Experiment 4
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vertical coding in Experiment 4
Number of subjects: 0
Study: 14707397

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 750 mg/day for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10409867

Group type: EXPERIMENTAL
Intervention: Closed circuit diving apparatuses (breathing gas compositions: 24 m: 60% O2/40% N2, 42 m: 40% O2/60% N2, 54 m: 32.5% O2/67.5% N2)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Compressed air diving apparatuses (breathing gas: 21% O2/78% N2)
Number of subjects: 15
Study: 7676787

Group type: EXPERIMENTAL
Intervention: Propofol with 1.0 mg alfentanil
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 400

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 400
Study: 2305332

Group type: EXPERIMENTAL
Intervention: Pivampicillin (700 mg twice daily for 9 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Doxycycline (200 mg on the first day, then 100 mg daily plus one placebo tablet for 9 days)
Number of subjects: 80
Study: 437309

Group type: EXPERIMENTAL
Intervention: Phyllocontin Continus tablets
Number of subjects: 37
Study: 31919540

Group type: EXPERIMENTAL
Intervention: 2 mA tDCS
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 4 mA tDCS
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 16
Study: 31864818

Group type: EXPERIMENTAL
Intervention: Open-construct PEEK anchor
Number of subjects: 69

Group type: COMPARATOR
Intervention: Non-vented biocomposite anchor
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both groups (Open-construct PEEK anchor and Non-vented biocomposite anchor)
Number of subjects: 69
Study: 30586441

Group type: EXPERIMENTAL
Intervention: Birth kit use
Number of subjects: 3317
Study: 27146504

Group type: EXPERIMENTAL
Intervention: Lichtenstein repair
Number of subjects: 67

Group type: COMPARATOR
Intervention: Darning repair
Number of subjects: 67
Study: 24457604

Group type: EXPERIMENTAL
Intervention: UPA 5 mg
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: UPA 10 mg
Number of subjects: 237

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study: 22980429

Group type: EXPERIMENTAL
Intervention: 3% acetic acid gel
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 48
Study: 20195952

Group type: EXPERIMENTAL
Intervention: Maternal serum IL-6 above the 90th percentile
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Maternal serum CRP above the 90th percentile
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Maternal serum IL-6 and CRP above the 90th percentile
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Maternal serum MMP-9
Number of subjects: 475
Study: 17263884

Group type: EXPERIMENTAL
Intervention: IL-2 therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: No IL-2 therapy (Control)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Baseline CD8(+) T cell apoptosis
Number of subjects: 14
Study: 16178407

Group type: EXPERIMENTAL
Intervention: Canalith repositioning maneuver with postmaneuver activity restrictions (restricted group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Canalith repositioning maneuver without postmaneuver activity restrictions (nonrestricted group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Postmaneuver restrictions
Number of subjects: 42
Study: 12109340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10540675

Group type: EXPERIMENTAL
Intervention: Double paper wipe cleaning method for fit patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single paper wipe followed by alcohol wipe for patients at risk of infection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single paper wipe followed by alcohol wipe for patients with a potential source of infection
Number of subjects: 0
Study: 8983287

Group type: EXPERIMENTAL
Intervention: SCM test using the Cellscan system
Number of subjects: 153
Study: 1752914

Group type: EXPERIMENTAL
Intervention: temazepam Gelthix (TG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: liquid-filled soft gelatin capsules (TL)
Number of subjects: 24
Study: 6810204

Group type: EXPERIMENTAL
Intervention: Sinemet (levodopa plus carbidopa)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbidopa
Number of subjects: 0
Study: 30463437

Group type: EXPERIMENTAL
Intervention: Soybean oil-based diets with 6.30% fat
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Soybean oil-based diets with 13.9% fat
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Soybean oil-based diets with 22.0% fat
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Soybean oil-based diets with 34.0% fat
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Soybean oil
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Soybean oil-based diets
Number of subjects: 16
Study: 28281736

Group type: EXPERIMENTAL
Intervention: Genotyping
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Platelet function testing (PFT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study: 27119309

Group type: EXPERIMENTAL
Intervention: Left axillary implantation of ILR
Number of subjects: 63

Group type: COMPARATOR
Intervention: Traditional left chest area implantation of ILR
Number of subjects: 63
Study: 24612007

Group type: EXPERIMENTAL
Intervention: MMS health messages in local languages sent to the intervention group over 6 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (no MMS health messages)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: MMS health messages in local languages
Number of subjects: 53
Study: 22390878

Group type: EXPERIMENTAL
Intervention: Basic print‐delivered intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basic Web‐based intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Print‐delivered intervention with an additional environmental component
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web‐based version with an additional environmental component
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pretest results
Number of subjects: 0

Group type: COMPARATOR
Intervention: Print‐delivered and Web‐based interventions
Number of subjects: 0
Study: 20849613

Group type: EXPERIMENTAL
Intervention: Community mobilisation intervention through women's groups
Number of subjects: 48000

Group type: EXPERIMENTAL
Intervention: Volunteer-led infant feeding and care support intervention
Number of subjects: 48000

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 48000
Study: 17437498

Group type: EXPERIMENTAL
Intervention: Dideco 703 (D703)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dideco 903 (D903)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Quadrox
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All oxygenators
Number of subjects: 60
Study: 15812103

Group type: EXPERIMENTAL
Intervention: Community pharmacy-based coaching program including a take-home videotape
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 147
Study: 11916761

Group type: EXPERIMENTAL
Intervention: 50 mg FeSO4 twice daily for 6 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo twice daily for 6 weeks
Number of subjects: 41
Study: 9864077

Group type: EXPERIMENTAL
Intervention: Lithium (serum drug level 0.6+/‐0.1 mmol/L)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Carbamazepine (serum drug level 6.1+/‐1.3 microg/mL)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 171

Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 171
Study: 8471984

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide with low dose alpha-interferon (IFN)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Cyclophosphamide alone (Control)
Number of subjects: 34
Study: 3107374

Group type: EXPERIMENTAL
Intervention: Wet cryoprecipitate
Number of subjects: 5

Group type: COMPARATOR
Intervention: Lyophilized cryoprecipitate
Number of subjects: 5

Group type: COMPARATOR
Intervention: Fraction I-O
Number of subjects: 5
Study: 30372588

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 210
Study: 27580688

Group type: EXPERIMENTAL
Intervention: PCV13 followed by PPSV23 (prime-boost group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: PPSV23 alone (PPSV23-alone group)
Number of subjects: 64
Study: 25525163

Group type: EXPERIMENTAL
Intervention: Dietary supplement (vitamin C, E, zinc, lutein/zeaxanthin, selenium, taurine, Aronia extract, omega-3 free fatty acids)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 22849546

Group type: EXPERIMENTAL
Intervention: 10-day sequential therapy (5 days of lansoprazole and amoxicillin followed by 5 days of lansoprazole, clarithromycin, and metronidazole)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Conventional triple therapy (10 days of lansoprazole, amoxicillin, and clarithromycin)
Number of subjects: 159
Study: 20152599

Group type: EXPERIMENTAL
Intervention: Anterior capsule polishing
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unpolished eyes (control)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clinical comparison of polished vs unpolished eyes
Number of subjects: 20
Study: 17432784

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg once daily for 3 days after extraction
Number of subjects: 400

Group type: COMPARATOR
Intervention: Physiologic saline 3 times daily from 24 hours after extraction for 7 days
Number of subjects: 400
Study: 16137195

Group type: EXPERIMENTAL
Intervention: Microsatellite polymorphisms in XRCC1, XRCC3 and XRCC5
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Rare XRCC1 [AC]11 and [AC]21 repeats
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Microsatellite repeat length in XRCC1 and XRCC5
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: XRCC3 [AC]16 homozygotes
Number of subjects: 62
Study: 11870500

Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg day(-1) orally) + 5-fluorouracil (200 mg day(-1))
Number of subjects: 64

Group type: COMPARATOR
Intervention: 5-fluorouracil alone
Number of subjects: 64
Study: 10447370

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB) 200 microg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 8949823

Group type: EXPERIMENTAL
Intervention: LS (lateral insertion, sitting withdrawal)
Number of subjects: 88

Group type: COMPARATOR
Intervention: LL (lateral insertion, flexed lateral withdrawal)
Number of subjects: 88

Group type: COMPARATOR
Intervention: SL (sitting insertion, lateral withdrawal)
Number of subjects: 88

Group type: COMPARATOR
Intervention: SS (sitting insertion, sitting withdrawal)
Number of subjects: 88
Study: 2024754

Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine 1.5 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 60
Study: 7263877

Group type: EXPERIMENTAL
Intervention: Rational-emotive therapy (RET)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Attention placebo counseling program (control)
Number of subjects: 148

Group type: COMPARATOR
Intervention: No-treatment group (control)
Number of subjects: 148
Study: 31185613

Group type: EXPERIMENTAL
Intervention: Suicide prevention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 28183585

Group type: EXPERIMENTAL
Intervention: Oblique view (group O)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Transverse view (group T)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Longitudinal view (group L)
Number of subjects: 126
Study: 24132814

Group type: EXPERIMENTAL
Intervention: SOMA (somatostatin 300 μg/hour and heparin 70 mIE/kg/min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: SALINE (saline infusion)
Number of subjects: 6
Study: 20682548

Group type: EXPERIMENTAL
Intervention: Short-term gemcitabine and paclitaxel chemotherapy (arm A)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Prolonged gemcitabine and paclitaxel chemotherapy (arm B)
Number of subjects: 96
Study: 19330493

Group type: EXPERIMENTAL
Intervention: Fixed-dose manidipine/delapril
Number of subjects: 110

Group type: COMPARATOR
Intervention: Losartan/hydrochlorothiazide
Number of subjects: 110
Study: 17570342

Group type: EXPERIMENTAL
Intervention: Single session of behavioral treatment involving self-exposure instructions
Number of subjects: 0
Study: 15297125

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Physiotherapy (pulsed ultrasound, deep friction massage, exercise programme)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Topical nonsteroid anti-inflammatory drugs
Number of subjects: 46

Group type: COMPARATOR
Intervention: Acupuncture, extracorporeal shock wave therapy, manipulation, orthoses, low-energy laser, glycosaminoglycan polysulfate injection, botulinum toxin injection, topical nitric oxide application
Number of subjects: 46
Study: 11598479

Group type: EXPERIMENTAL
Intervention: Calcium dobesilate for two weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: High-fiber diet (Control)
Number of subjects: 29
Study: 9505735

Group type: EXPERIMENTAL
Intervention: Bispectral index monitoring (Group 2, n = 28)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Classical signs of depth of anaesthesia (Group 1, n = 30)
Number of subjects: 58
Study: 8838609

Group type: EXPERIMENTAL
Intervention: Fenfluramine (20, 40 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 2654034

Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 0
Study: 891280

Group type: EXPERIMENTAL
Intervention: 5 mg of fenoterol hydrobromide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 7.5 mg of fenoterol hydrobromide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 10 mg of fenoterol hydrobromide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 24 mg of ephedrine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31840327

Group type: EXPERIMENTAL
Intervention: Cannabis use (ASSIST)
Number of subjects: 2746

Group type: EXPERIMENTAL
Intervention: Alcohol use (AUDIT)
Number of subjects: 2746
Study: 30421844

Group type: EXPERIMENTAL
Intervention: Gelesis100
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27653813

Group type: EXPERIMENTAL
Intervention: Minimal extracorporeal circulation circuit (MECC, Maquet)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Extracorporeal circulation circuit optimized (ECC.O, Sorin)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional extracorporeal circuit (CECC, Maquet)
Number of subjects: 60
Study: 26104909

Group type: EXPERIMENTAL
Intervention: Single-session small-group discussion on liver cancer and HBV testing
Number of subjects: 1123

Group type: COMPARATOR
Intervention: Similar session on physical activity and nutrition (Control)
Number of subjects: 1123
Study: 24065259

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced sonography with intravenous administration of 2.4 mL of sulfur hexafluoride
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced sonography
Number of subjects: 25

Group type: COMPARATOR
Intervention: Serologic data
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Sonographic results (judged by RBV)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Sonography for local (extramedullary myeloma) response
Number of subjects: 25
Study: 21332811

Group type: EXPERIMENTAL
Intervention: Anti-cellulite cream
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 18647258

Group type: EXPERIMENTAL
Intervention: Mean model recommended for use in economic evaluation.
Number of subjects: 0
Study: 18162022

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 836